About this trial
Thyroiditis includes inflammatory thyroid disorders such as Hashimoto's thyroiditis and subacute thyroiditis. These conditions may cause thyroid pain, neck tenderness, elevated inflammatory markers, thyroid dysfunction, fatigue, and recurrence. Current management includes observation, symptomatic treatment, nonsteroidal anti-inflammatory drugs, and corticosteroids. Although corticosteroids may be effective, relapse after tapering and treatment-related adverse effects remain limitations. Colchicine is hypothesized to reduce inflammatory activity and may improve biochemical and clinical recovery. This study will evaluate the efficacy and safety of low-dose colchicine compared with corticosteroid therapy and supportive care in adults with autoimmune or subacute thyroiditis.
Eligibility criteria
Qualifiers
Age 18 to 70 years
Newly diagnosed Hashimoto's thyroiditis or Subacute thyroiditis
Diagnosis confirmed clinically, biochemically, and ultrasonographically
Ability to provide written informed consent
Disqualifiers
Pregnancy or breastfeeding
Severe renal impairment
Severe hepatic disease
Cytopenia
Trial design
Treatments tested in this trial
- colchicine
- Prednisolone
- NSAID
Treatment groups
Locations
Sponsors and collaborators
Mansoura University
Lead sponsor
Saudi German Hospital - Madinah
Collaborator